MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jso.70399

Медицинская библиотека · Journal of surgical oncology · 2026

Treatment Selection and Survival In Muscle-Invasive Bladder Cancer: Real-World Data on the Impact of Geriatric-8 Screening.

Okumura Gaku, Yajima Shugo, Ikezoe Erika, Gozu Shu, Imasato Naoki, Hirose Kohei, Kataoka Madoka, Nakanishi Yasukazu, Masuda Hitoshi

СтатьяПеревод в очереди

Аннотация

AIM: Standard treatment for muscle-invasive bladder cancer (MIBC) includes radical cystectomy (RC), a highly invasive procedure. We evaluated the utility of the Geriatric-8 (G8) screening tool in guiding treatment and whether the survival benefit of RC differs by G8 score.

METHODS

We retrospectively reviewed patients with non-metastatic MIBC who underwent G8 assessment (2020-2024). Patients were grouped by G8: low (<11), intermediate (11-14), and high (>14). Treatment patterns and the effectiveness of RC were evaluated.

RESULTS

A total of 152 patients were included (high: n = 55, intermediate: n = 67, low: n = 30). RC was performed in 124 patients (81.6%). Lower G8 was linked to older age, poorer performance status, and dependent instrumental activities of daily living (p < 0.01). Neoadjuvant chemotherapy followed by RC was more frequently planned in the high G8 group (81.8% vs. 53.7% vs. 26.7%, p < 0.0001), while immediate RC was a more common plan in the low G8 group (14.5% vs. 41.8% vs. 53.3%, p = 0.0003). RC was associated with significantly improved overall survival, and the benefit persisted after propensity score matching (p = 0.0013). Inverse probability of treatment weighting, which retained the whole cohort, gave a consistent estimate (hazard ratio [HR] 0.17, 95% confidence interval [CI] 0.08-0.39). Subgroup estimates were less precise in the low G8 group (HR 0.57, 95% CI 0.12-2.73) than in the intermediate (HR 0.14, 95% CI 0.06-0.33) and high (HR 0.10, 95% CI 0.02-0.39) groups. In sliding window analysis, HR estimates were higher at G8 < 9, with wide CIs. Similar results were observed for cancer-specific survival.

CONCLUSIONS

RC was associated with a survival benefit in patients with intermediate and high G8 scores, whereas the evidence in the low G8 group was limited and inconclusive; careful risk-benefit evaluation remains warranted in this group.

Для цитирования: Okumura Gaku, Yajima Shugo, Ikezoe Erika, Gozu Shu, Imasato Naoki, Hirose Kohei, Kataoka Madoka, Nakanishi Yasukazu, Masuda Hitoshi. Treatment Selection and Survival In Muscle-Invasive Bladder Cancer: Real-World Data on the Impact of Geriatric-8 Screening.. Journal of surgical oncology. 2026. DOI: 10.1002/jso.70399.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.